MRA technology, while promising, is still emerging in many regions. The initial investment for equipment and training can be high, leading to higher costs for patients. Additionally, insurance providers may not fully cover these tests, limiting their adoption. However, as the technology becomes more mainstream, costs are expected to decrease, improving accessibility.